Abstract: AIM: To assess the proteome of normal versus tumor of squamous cell carcinoma of esophagus (SCCE) 
Introduction
As a complex disease, cancer arises from a range of genetic alterations resulting to changes both in structure and function of the cell. Such changes include up and down regulation of certain genes, mutations, chromosomal alterations, suppression or activation of specific genes, that overall confer cells with growth advantage and clonal expansion (1, 2) . As a result, cells acquire the ability to produce new proteins, but others which normally are present may be modified, reduced, augmented or even eliminated (3, 4) . Proteomics has provided simultaneous analysis of a large number of cellular protein constituents as well as the most powerful direct analytical method of protein detection and evaluation (5, 6). However in developing countries, it ranks fourth and occurs with high frequencies in certain regions of the world, such as Iran, China, South Africa and France characterized with five-year survival rate as low as 8% (7, 8) . Noteworthy among these molecular alterations is the down regulation of the important tumor suppressor genes and consequently their protein products such as protein 53KDa (P53), Retinoblastoma( RB), Mutated in Colon Carcinoma (MCC), and Deleted in Colon Carcinoma(DCC) (9) which further indicate the importance of Tumor Suppressor (TSs) in the carcinogenesis of this type of cancer. The present report represents an extension of our earlier work on esophageal cancer (10 ) .
Materials And Methods

Chemicals
All chemicals were purchased from Sigma unless otherwise specified.
Patients and tissue sampling
Tissue samples were collected immediately after surgery, wrapped in aluminum foil, snap frozen in liquid nitrogen and maintained at -70℃. The age of the patients at the time of diagnosis ranged from 27 to 86 years (63% males, 37% females) with mean of 55 years.
Protein preparation
100-150 mg of tissues were sliced on ice and pulverized under liquid nitrogen using a microdismemberator (Braun, Germany). Subsequently 600 µL homogenization buffer (10 mmol/L Tris-HCL (BioRad), 5 mmol/L MgCl2 PH 7.4) was added to the pulverized tissues, mixed and 10 µL of the following protease inhibitors: pepestatin (1 mg/mL in isopropanol), benzamidine (16 mg/mL in H2O), phenylmethylsulphonyl fluoride (PMSF at 25 mg/mL in isopropanol) were added. To this homogenate, 10 µl of RNaseA (10 mg/mL in homogenization buffer) and DNase I (1 mg/mL in homogenization buffer) were added and incubated on ice for 20 min. Subsequently, urea at 7 mol/L, thiourea at 2 mol/L, 5% ß-mercaptoethanol and 0.5% SDS were gradually added and the volume of solution was adjusted to 1.5 mL with the homogenization buffer. Samples were centrifuged at high speed for removal of insoluble particles and five microliters of which was used for protein concentration assessment using Bradford assay.
Two-dimensional electrophoresis
Samples were subjected to isoelectrofocusing (IEF) following to adaptation and slight modifications (11) .
Protein detection
Proteins were detected using a slight modification of the previously reported method (11) .
Isoelectric point determination
Isoelectric point (pI) of polypeptides was determined by either application of protein PI markers (Sigma) or by determining PI change along the entire length of first dimension gel (12) .
Image analysis
Silver-stained gels were scanned using calibrated GS-800 densitometer (Bio-Rad) at resolution of 600 dots and 12-bits per inch. Spot detection and gel matching were done according to Melanie-4 default settings and spot pairs were investigated visually (GeneBio, Geneva, Switzerland).
Immunological detection and localization of actin
Following to 2-DE, gels were equilibrated for 30 min in transfer buffer and polypeptides were electrophoretically transferred to the nitrocellulose membranes at 14 V overnight. Membranes were blocked for 2 h in blocking solution and exposed to biotinylated anti-actin antibody at 1/3000 dilution for 1 h with constant shaking. Membranes were subsequently washed 3X with TBST, incubated with strptavidin conjugated alkaline phosphatase in TBST at 1/4000 dilution and further incubated (1 h) with constant shaking. Membranes were washed two times with TBST, once with TBS and exposed to color solution. To stop excess color formation membranes were washed with distilled water( 13) .
RNA extraction and RT-PCR of TMß and beta actin
Total RNA was extracted by acid phenol method and the first strand cDNA was synthesized applying oligo d (T) 18 (Roche). Subsequently amplification was carried out using forward primer; 5'-GGC TGA TGA GAG CGA GAG AG-3' and the reverse primer 5'-GCA CTG GCC AAG GTC TCT TC-3' for amplification of TMß and 5'-TGA CGG GGT CAC CCA CAC TGT GCC CAT CTA-3' as forward and 5'-CTA GAA GCA TTT GCG GTG GAC GAT GGA GGG-3' as reverse primers for amplification of beta actin. PCR condition was composed of primary denaturation at 95℃ 1 min followed by 30 cycles of amplification according to subsequent scheme; denatuartion 1 min at 95℃, annealing at 56℃ 1 min and extension at 72℃ 1 min and final extension at 72℃ for 10 min. Subsequently 4 µL of the PCR product was used for agarose gel electrophoresis.
Mass spectrometry
Silver stained protein spots containing the proteins of interest were destained thoroughly with 1% H 2 O 2 (typically 1 min) and lyophilized to dryness [14] . Silver stain removal using H 2 O 2 was performed to enhance peptide adsorption by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI) (14) . Mass spectra were acquired using a MALDI-TOF/TOF mass spectrometer (Voyager 4700, Applied Biosystems, Foster City, CA). Spectra were submitted to Mascot (http://matrixscience.com) for peptide mass fingerprinting.
Results
Protein extraction, 2DE and image analysis
For further verification whether an equal amount of protein from either types of tissues were applied, immunological detection of actin (Figurers 1B and 2B) was carried out following to 2DE as internal control of loading. The densitometry map contained almost 800 features ranging in the molecular masses from 10 to 220 kDa and pIs from 4.8 to 8.0. For deciphering tumor-associated polypeptides, 2DE gels of tumor tissues were compared with their corresponding matched normal tissues. Comparing with the matched normal tissues, 92 definite proteins (spots) in 2DE gels from 45 tumor tissues belonging to 45 patients were found becoming subjected to lower levels of expression. These spots were 7 out of 92 spots that have undergone lower levels of expression and 7 out of 88 spots which have shown higher levels of expression respectively. Figures 1A and 2A represent the resulting 2DE gels of the normal and the corresponding tumor tissues of one of the patients. The 14 observed differentially abundant proteins are indicated by arrows ( Figures 1A and 2A) . The proteins that were observed with decreased abundance in tumors compared with their corresponding normal tissues are labeled alphabetically as A, B, C, D, E, F and G. Spots B, C and E are observed in a chain of spots and likely indicate that they are isoforms or modified form of a specific protein. On the other hand those proteins that were observed to have an increased abundance in tumors were numbered as 1, 2, 3, 4, 5, 6 and 7. The apparent molecular weight of polypeptides, approximate isoelectric points and changes in expression level is presented in Table 1 . It was found that spot A was absent in tumor samples whereas, spots B, C, D and E were considerably and spots F and G were shown more than two folds of down regulation. It is suggested that down regulated proteins to be involved in the maintenance of normal phenotype whereas the other up-regulated polypeptides in development of malignanancy. 
Mass spectrometric analysis, identification of polypeptides and RT-PCR
Following to 2DE, spots of interest were excised, in gel digested and analyzed with MALDI/TOF/TOF(Matrix-assistedlaser desorption/Ionization/ Time of Flight/Time of Flight ) mass spectrometer. The observed peptide mass spectra were analyzed for protein identification by peptide mass fingerprinting that resulted to the identification of all the 14 proteins which are listed in Table 1 . The identified protein corresponding to spot A was found to be ß-tropomyosin . As was mentioned above this protein was found to be lost in tumors thus for further validating results achieved regarding with TMß, RT-PCR was conducted by applying TMß specific primers. As Figure 4A indicates the 431bp amplification product is only limited to the cDNA synthesized from RNA extracted from normal tissue. Applying beta actin as an internal control of RT-PCR which gives rise to 670bp amplification product ( Figure 4B ) along with running the extracted RNA ( Figure 4C ) indicate that lack of amplification in tumor tissues should be due to loss of expression of TMß. These observation further points out that down regulation of TMß occur at transcriptional level in SCCE. As discussed later on in discussion, TMß is a down stream target for several oncogenes and function as a tumor suppressor gene. 
Discussion
Former studies on SCCE have led to the identification of Annexin I (15, 16) , tumor rejection antigen (gp96) 16, clustrin (17) , tropomyosin 3, retinoblastoma binding like protein and K506 binding protein (18) For instance loss of TMß in breast cancer (19) , myosin light chain 2 isoforms in transformed osteosarcoma (20) , peroxiredoxin II in pancreatic adenocarcinoma (21) , calreticulin in bladder (22) and colon cancers (23) , HSP70 in hepatocellular (4) and keratin 1 in gastric carcinoma cell lines (24) . Studies on other types of cancers such as oral tongue squamous carcinoma (25) and carcinomatous breast lesions (26) have also led to this observation. Different studies have indicated that TMß functions as a tumor suppressor. For example reversion of neoplastic phenotype, anti-angiogenic activity (27, 28) , induction of slow growth rate, anchorage, cytoskeleton organization in breast cancer MCF7 cell lines and anoikis (29) are all the consequence of TMß expression. TMß is required for cytoskeleton establishment andmediation of TGF-ß mediated stress fiber formation. Alternatively Ras-ERK pathway antagonizes with TGF-ß induced stress fiber formation by suppressing TMß expression (30) . Indeed TMß is a down stream target for ras oncogene (31) . To the best of our knowledge, no strong evidence has been documented regarding with the involvement of the ras family of oncogenes in esophageal carcinogenesis, therefore it is likely that other oncogenes may be involved in down regulation of TMß such as TGF-a and activation of EGFR; both of which participate in down regulation of TMa and ß (32) . Interestingly high level of TGF-a was reported in all gastrointestinal cancers including the late stages of esophageal cancer [33] along with amplification of EGFR in esophageal cancer (34) . Loss of TMß in tumors suggests that this protein may play an important role in tumor suppression of esophageal carcinogenesis.
In addition to TMß, down regulation of several other proteins was also observed in this study, among which annexin I. Loss of annexins I expression was reported in tumors including esophagus and prostate as an early event (15) and in cell lines such as B cell non Hodgkin's lymphoma along with hypermethylation of promoter (35) . Annexin I induces both spontaneous and caspase 3 activated apoptosis (36) . Zhi et al (37) have demonstrated inhibition of growth, colony formation and tumorigenesis of EC9706; an esophageal carcinoma cell line in nude mice following to transfection with annexin I. Furthermore mutations in p53 were also found to result in down regulation of annexin 10, another member of annexins family in hepatocellular carcinoma, along with vascular invasion, early recurrence and poor prognosis (38) . We formerly showed mutations in the p53 tumor suppressor gene in SCCE (10) , thus it is possible that such mutations correlate with down regulation of annexin 10 as well as annexin I. It is well demonstrated that EGFR amplification occurs in SCCE (34) . On the other hand annexin I undergo phosphorylation and inactivation by EGFR (39) . Thus our result additionally supports former report (16) regarding with loss of annexin I in SCCE.
They also inhibit NF?B and tumor necrosis factor a in response to external H 2 O 2 and H 2 O 2 induced expression of proapoptotic protein; BAX (40, 41) . Thus it is possible that loss or down regulation of this protein or other members of detoxifying enzymes in esophageal epithelium which normally could be exposed to stresses contribute to the carcinogenesis by cellular failure in detoxification of oxidative agents affecting this tissue.
Loss of muscle forming proteins is important cause of body weight loss or cachexia in cancers primarily due to loss of myosin heavy chain (42) . Myosin light chain 2 is indispensable component of cytoskeleton, migration and apoptosis (43) . Down regulation of myosin light chain 1 and myosin regulatory light chain 2 proteins was shown in oral tongue squamous cell carcinoma (25) . Supporting our results is the report of Samoszuk et al. that have formerly shown up-regulation of this protein in clonogenic human breast cancer (44) . We also found several up-regulated proteins in tumors, among which heat shock protein 70. Investigations in cancers such as gastric, hepatocellular and colonic adenocarcinoma have indicated higher levels of expression of HSP70 along with other stress associated proteins (4, 45) . HSP70 exerts antiapoptotic activity by suppressing tumor necrosis factor induced apoptosis and caspase 3 down stream events (46) , interfering with SAPK/JNK and ceramide induced apoptosis and cleavage of caspase 3 substrate enzyme; PARP which is involved in DNA repair (47) . Theses findings has raised the idea that HSP70 not only should be considered as a tumor marker for HCV caused hepatocellular carcinoma (48) but also as a target for cancer treatment (49) . Calreticulin and keratin 1 were among other up-regulated proteins in tumors. The involvement of calreticulin in tumors has been reported by several groups. Rendon Huerta et al (50) have shown that protein kinase C isoforms bind and phosphorylate calreticulin. This would suggest a possible role for calreticulin in signal transduction and involvement in cell division. It was also found that calreticulin regulates p53 function by affecting its rate of degradation and nuclear localization (51) . Thus association of p53 mutations with esophageal carcinogenesis [10] as well as p53 degradation could explain the role of calreticulin in the development of esophageal tumor. Added to calreticulin we found overexpression of Keratin 1, a member of keratin family in SCCE. Formerly Trask and colleagues have shown different expression pattern of keratin isoforms in normal versus tumors (52) . They proposed the expression pattern of keratin isoforms as biomarkers for differentiating normal from malignant cells. Furthermore Kinjo and coworkers have shown overexpression of keratin 1 in colonic adenocarcinoma cells (53) and Nishikawa et al (24) have found up to 17 folds of truncated keratin 1 in Epstein-Barr virus transfected gastric carcinoma cell lines. In esophageal cancer several groups have reported an increased level of cytokeratin 19 (keratin 19) in serum and secretion by cell lines (54) . The later groups have proposed cytokeratin 19 to have the best specificity and sensitivity as a prognostic marker for evaluating esophageal cancer. Thus involvement of another member of keratin family in SCCE not only supports former results but also introduces a new marker from this family.
The aberrantly expressed protein activates several protein kinases such as IP3 kinase, STAT5 and transcription factors which end up to mitogenic effects (55) . The fusion of ALK with nucleoplasmin is frequently observed in ALCL. Walking on chromosme 2, Lamant et al. have shown the fusion of tropomyosin 3 and ALK as a result of t(1;2) (q25;p23) (56) . Further studies led to the identification of not only TM3-ALK but also TM4-AKL fusion proteins in patients with inflammatory myofibroblastic tumors (57) and as a result perturbation of normal tumor suppressor activity of TM isoforms There were also three other proteins found in SCCE as homologues of formerly identified proteins in other organisms. Thus we interpret them to be newly found proteins in SCCEIn conclusion this is the first report on proteomic analysis of SCCE from Iran, a country with the highest incidence rate of SCCE (8) . We were able to identify fourteen differentially expressed proteins in esophageal tumors. Our study further showed that several proteins which are commonly affected in other digestive organs as well as liver are also affected in SCCE which may additionally explain a common molecular mechanism for digestive system tumorigenesis and putative candidate biomarkers. To our knowledge while up to now not a general molecular marker has been introduced for cancers, however finding disappearance of TMß in SCCE could introduce a useful tumor marker for SCCE diagnosis, evaluation and follow up. 
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